Lifestyle program for smoldering myeloma and MGUS
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether a 12-month lifestyle program (including diet and exercise) can improve health markers in people with early blood conditions called smoldering myeloma or MGUS. The goal is to see if lifestyle changes can help delay or prevent the disease from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a diagnosis of smoldering multiple myeloma (SM) or monoclonal gammopathy of undetermined significance (MGUS) as confirmed by standard criteria.
- You must be generally able to carry out daily activities (performance status 0, 1, or 2).
- You must be able to speak, read, and understand English.
- You must be able to attend study visits and provide blood samples over a 12-month period.
- You must not have active multiple myeloma or evidence of organ damage (such as high calcium, kidney problems, anemia, or bone lesions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This 12-week pilot study tests whether a Korean-style Mediterranean diet, along with daily physical activity tracking, can help people with early blood conditions (MGUS or smoldering myeloma). The goal is to see if this approach is safe and may slow or prevent the condition from getting worse.
This study tests a lifestyle program that includes physical activity and nutrition guidance for people who have had multiple myeloma for at least a year. The goal is to see if this program helps improve quality of life and overall well-being.
This trial tests whether a whole-food, plant-based eating pattern—plus supplements or placebo—can improve health outcomes in people with MGUS or smoldering multiple myeloma. You may be asked to follow specific recipes and stop certain supplements, so it helps to confirm you can stick with the plan.
This study looks at how patients feel day to day (quality of life) while they are monitored or treated for MGUS or smoldering multiple myeloma. It is designed for people who do NOT yet have “myeloma defining events” or amyloidosis, because the goal is to understand well-being in earlier disease stages.
This study tests whether a plant-based diet and certain supplements can help people with smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS). Participants will learn to cook plant-based recipes and track their meals using a phone app.
This study tests whether a high-fiber plant-based diet can improve gut health in people with smoldering multiple myeloma. It aims to see if diet changes can slow or prevent the disease from progressing.
Hear when a new Monoclonal Gammopathy of Uncertain Significance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.